Surprise exit for Pfizer chief executive Jeffrey Kindler
December 6, 2010Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Jeffrey Kindler, Lipitor, Pfizer, Wyeth, executive succession
Pfizer’s chief executive Jeffrey Kindler has unexpectedly stepped down, saying his time at the helm of the world’s largest pharmaceutical …
NICE recommends MabThera for non-Hodgkin’s lymphoma
December 6, 2010Sales and Marketing MabThera, NICE, Rituxan, Roche, non-Hodgkin’s lymphoma, rituximab
NICE has given a preliminary green-light to Roche’s MabThera for use as a maintenance therapy for non-Hodgkin’s lymphoma. The Institute’s …
A mature approach to relationships with pharma’s customers
December 6, 2010Sales and Marketing MSI, Paul Stuart Kregor, franchise management, pharma marketing
Commercial managers who are responsible for a number of brands face a constant challenge in choosing where across the franchise …
Apitope appoints Hayley French
December 6, 2010Research and Development, Sales and Marketing Apitope, Hayley French, appointment, research and development, sales and marketing
Belgium-based biopharmaceutical company Apitope has appointed Hayley French to its management team as commercial director. She will be responsible for …
Caligor Rx strengthens its European Team
December 3, 2010Research and Development Caligor Rx, Jacquelyn May, Jess McKenna, appointment, research and development
Clinical trial procurement firm Caligor Rx has appointed Jess McKenna head of quality assurance and customer relationships and Jacquelyn May …
Digital Pharma: NHS extends online service comparisons
December 3, 2010Medical Communications Digital Pharma blog, NHS Choices, maternity services, patient information
The NHS has launched a new online comparison service to allow expectant parents in England to compare and rate maternity …
The specifics of early access programmes
December 3, 2010Sales and Marketing Expanded Access Programs, IDIS, early access programmes, named patient programmes
With increasing requests from healthcare professionals and patients globally for access to drugs that are still in clinical development or …
Merck acquires innovative insulin firm SmartCells
December 3, 2010Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin
Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …
Creston makes £20m US coms acquisition
December 3, 2010Medical Communications Alembic Health Communications, Cooney Waters, Creston, Intensity Digital, Red Door Communications, medicial communications
Creston, the group which owns UK healthcare PR shop Red Door Communications, is to buy two US health and pharma …
UK pharma faces rising costs from value-based pricing
December 3, 2010Sales and Marketing Eli Lilly, VBP, lilly, value-based pricing
The government’s planned introduction of a value-based pricing system in the UK could increase costs and bureaucracy for the industry, …
Novartis to cut 1,400 US sales jobs
December 2, 2010Sales and Marketing Novartis, Novartis Pharma North America, Novartis Pharmaceuticals Corporation, job cuts, sales representatives
Novartis has outlined a major restructure of its US field force of sales reps that will see 1,400 positions cut …
Tolerx to collaborate on first-in-class cancer antibody
December 2, 2010Research and Development Cancer, T cell, Torelx, monoclonal antibody
US biopharma company Tolerx is to work with a non-profit cancer research fund to develop its first in class antibody …
CME Spotlight: medical communications evolves
December 2, 2010Medical Communications CME, CME Spotlight, Continuing medical education, Eugene Pozniak
I recently attended the first meeting of the MedComms Forum in Oxford. The venue of the Natural History Museum was …
Colour management for the pharmaceutical industry
December 1, 2010Manufacturing and Production colour management, packaging, pharma printing
The development and adoption of pharmaceutical specific quality standards by the printing industry has played a vital role in the …
EMA to widen public access to documents
December 1, 2010Research and Development, Sales and Marketing EMA, European Medicines Agency, European Ombudsman, patient information, transparency
The European Medicines Agency has agreed to give greater access to documents on medicines for human and veterinary use, after …
New chief executive for Merck & Co
December 1, 2010Manufacturing and Production, Research and Development, Sales and Marketing Kenneth Frazier, Merck, Merck & Co, Richard Clark, Schering-Plough
Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …
Dr Martino Picardo to lead Stevenage Bioscience Catalyst
December 1, 2010Research and Development Dr Martino Pacardo, Stevenage Bioscience Catalyst, appointment, research and development
New UK science park Stevenage Bioscience Catalyst (SBC) has appointed Dr Martino Picardo as its first chief executive. Dr Picardo …
New public health body to ‘nudge’ people on healthy living
December 1, 2010NHS reforms, Public Health England, alcohol, obesity, public health, smoking
Plans for a new organiation to oversee public health in England have been unveiled, which will ‘nudge’rather than nag people …
Change is needed, concedes NICE chief, but defends record
November 30, 2010Sales and Marketing Andrew Dillon, NHS reform, NICE, cost-effectiveness, health technology assessment, hta, value-based pricing
The chief executive of NICE acknowledges changes are needed in how drugs are assessed in the UK – including more …
UK pharma welcomes government reforms
November 30, 2010Manufacturing and Production, Research and Development, Sales and Marketing ABHI, ABPI, BIA, R&D tax credits, UK pharma, patent box
The UK pharma industry has responded warmly to government plans to review how best to create optimum conditions for private …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
